News About: Pharm. Industry
Sudo change name to Wooridul Life Sciences Ltd.Sudo Pharm said it will change its name to Wooridul Life Sciences Ltd. from September 5, citing image renovation as the main reason.
Founded in 1966, the company has set an a...
|
FTC organizes research conferenceThe Free Trade Commission, Korea’s law enforcement agency, said on September 3 it will hold its 5th conference of competition authorities and international organizations such as...
|
Ilyang awaits approval for ilaprazole in KoreaIlyang Pharm is soon expecting to receive marketing approval for ilaprazole, a new investigational proton pump inhibitor, from the Korea Food and Drug Administration as the KFDA...
|
Pharmaceutical firms urged to nurture cGMP technicians
Domestic drug makers need to take substantial measures to nurture GMP related professionals as concern is mounting that the construction plan of cGMP plant has been stalled due to the Korea won’s drastic fall.
Ther...
New recombinant antihemophilic factor approvedGreen Cross Corporation said on September 3 that the Korea Food and Drug Administration approved its new recombinant DNA-derived clotting factor to treat people with hemophilia ...
|
KPMA calls for scrapping of economic effectiveness evaluation system over medicines
The Korea Pharmaceutical Manufacturers Association (KPMA) has urged the government not to evaluate the economic effectiveness of conventional medicines to reduce their prices on a regular basis.
In a statement deli...
Kwangdong’s U to emerge as lead market
Kwangdong Pharm’s Uwhangchungsimwon (UC) is likely to regain its momentum as the market’s leading player Chosun Pharm is unable to release its products due to in-house problems, according to pharmaceutical business so...
Dongsung to distribute Genex’s Oral-LynDongsung Pharm says it has entered into an exclusive licensing and distribution agreement with the U.S. Generex biotechnology corporation for the importation, marketing, distrib...
|
Wyeth Korea reshuffles top deck
Wyeth Korea announced on September 1 that it has reshuffled eight top-level executives of its new business units.
The company said that the changes, which take effect starting September 1, have been made to reflec...
Ex-AZ China vice president named new AZ Korea presidentTom Keith-Roach, a former vice president of AstraZeneca China, has been appointed the new head of AstraZeneca Korea as of September 1.
“I'll make efforts to improve recogniti...
|
